What is the level of liabilities of Merck & Co this year?
Merck & Co has a debt balance of 69.09 B USD this year.
Merck & Co Liabilities 2024
Merck & Co Liabilities
69.09 B USD
Merck & Co Dividend yield
2.35 %
Ticker
MRK
ISIN
US58933Y1055
WKN
A0YD8Q
In 2024, Merck & Co's total liabilities amounted to 69.09 B USD, a 9.38% difference from the 63.17 B USD total liabilities in the previous year.
Merck & Co Aktienanalyse
What does Merck & Co do?
The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Merck & Co's Liabilities
Merck & Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Merck & Co's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Merck & Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Merck & Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Merck & Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Merck & Co Stock
What were the liabilities of Merck & Co compared to the previous year?
The liabilities of Merck & Co have increased by 9.38% increased compared to the previous year.
What are the consequences of high debt for investors of Merck & Co?
High liabilities can pose a risk for investors of Merck & Co, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Merck & Co?
Low liabilities mean that Merck & Co has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Merck & Co affect the company?
An increase in liabilities of Merck & Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Merck & Co affect the company?
A decrease in the liabilities of Merck & Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Merck & Co?
Some factors that can influence the liabilities of Merck & Co include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Merck & Co so important for investors?
The liabilities of Merck & Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Merck & Co take to modify the liabilities?
To change its liabilities, Merck & Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Merck & Co pay?
Over the past 12 months, Merck & Co paid a dividend of 2.96 USD . This corresponds to a dividend yield of about 2.35 %. For the coming 12 months, Merck & Co is expected to pay a dividend of 3.37 USD.
What is the dividend yield of Merck & Co?
The current dividend yield of Merck & Co is 2.35 %.
When does Merck & Co pay dividends?
Merck & Co pays a quarterly dividend. This is distributed in the months of July, October, January, April.
How secure is the dividend of Merck & Co?
Merck & Co paid dividends every year for the past 26 years.
What is the dividend of Merck & Co?
For the upcoming 12 months, dividends amounting to 3.37 USD are expected. This corresponds to a dividend yield of 2.68 %.
In which sector is Merck & Co located?
Merck & Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Merck & Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Merck & Co from 4/5/2024 amounting to 0.77 USD, you needed to have the stock in your portfolio before the ex-date on 3/14/2024.
When did Merck & Co pay the last dividend?
The last dividend was paid out on 4/5/2024.
What was the dividend of Merck & Co in the year 2023?
In the year 2023, Merck & Co distributed 2.8 USD as dividends.
In which currency does Merck & Co pay out the dividend?
The dividends of Merck & Co are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Merck & Co stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Merck & Co
Our stock analysis for Merck & Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck & Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
